Emcure Pharmaceuticals becomes the First Company in India to launch the 750 mg injectable variant of Ferric Carboxymaltose
Emcure Pharmaceuticals becomes the First Company in India to launch the 750 mg injectable variant of Ferric Carboxymaltose
NSE cautions investors from person named “Nilesh Agrawal” associated with “Grow Easy investment” | Caution for investors
NSE cautions investors from person named “Nilesh Agrawal” associated with “Grow Easy investment” | Caution for investors